Compare iShares MSCI Canada (TSX) (EWC) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Canada (TSX) vs Hinge Health Inc. Class A Common Stock — how do they compare? iShares MSCI Canada (TSX) trades at $59.18 (market cap $7.22B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, iShares MSCI Canada (TSX) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Canada (TSX) for 57 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| EWC | HNGE | |
|---|---|---|
Market Cap | $7.22B | $8.47B |
Volume | 1,285,678 | 1,624,526 |
Sector | Broad Market / Factor | Health |
52-Week High | $62.64 | $105.14 |
52-Week Low | $49.72 | $31.17 |
Typical Hold Time | 57 Days | 0 Days |
Enterprise Value | — | $8.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWC is trading at $59.91, up 0.77% with a bullish technical signal supported by moving averages. The stock shows neutral oscillator readings with RSI at balanced levels. Recent news highlights significant trade tensions between Canada and the US, with potential EU associate membership discussions creating both opportunities and risks for Canadian-focused investments.
The outlook remains cautiously optimistic given technical strength, but fundamental metrics are unavailable. Key risks include US-Canada trade war escalation and geopolitical uncertainties. Investors should monitor trade negotiations and economic data for directional cues on this Canada-focused equity.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Canada (TSX)
EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.
Read more on EWC →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
